NCT01320904

Brief Summary

Objective: To evaluate the effectiveness of neuromuscular electrical stimulation (NMES) combined with closed kinetic chain (CKC) exercises in patients with knee OA.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2010

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 23, 2011

Completed
Last Updated

March 23, 2011

Status Verified

March 1, 2011

Enrollment Period

2 months

First QC Date

March 22, 2011

Last Update Submit

March 22, 2011

Conditions

Keywords

Closed Kinetic ChainNMESKnee Osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the flexibility of the posterior chain muscles

    We only observed a significant improvement in the flexibility of the posterior muscle chain for the CKC + NMES group during the initial evaluation compared to the partial evaluation (p=0.012), the partial evaluation compared to the final evaluation (p=0.035) and the initial evaluation compared to the final evaluation (p=0.008). Regarding the scale that was used to classify the level of flexibility, 10% of the subjects in the CKC + NMES group were initially classified as good/excellent. At the end of the protocol, 60% of the subjects were classified as good/excellent (p=0.015)

    6 months

Secondary Outcomes (1)

  • Evaluation of hamstring and quadriceps muscle strength

    6 months

Study Arms (2)

Closed Kinetic Chain and NMES placebo

PLACEBO COMPARATOR

During the stimulation period the patient remained in a mini-squat position at thirty degrees and returned to zero degrees during the decay period. During the electrical stimulation off period, the patient spontaneously performed another mini-squat at 30 degrees without electrical stimulation. The patients in the CKC + NMES placebo group simulated the same work applied to the NMES group. Notably, this group was also connected to the electrodes, but the equipment was set at a stimulus intensity of zero. We used a 10-channel electrical stimulation device with a 2500-Hz carrier frequency. We used four channels in the synchronous mode, with surface electrodes that were simultaneously fixed at the motor points of the quadriceps and hamstrings.

Procedure: NMES

Closed Kinetic Chain Group

OTHER

During the stimulation period, i.e., the on time, the patient remained in a mini-squat position at thirty degrees and returned to zero degrees during the decay period. During the electrical stimulation off period, the patient spontaneously performed another mini-squat at 30 degrees without electrical stimulation. The patients in the CKC + NMES placebo group simulated the same work applied to the NMES group. Notably, this group was also connected to the electrodes, but the equipment was set at a stimulus intensity of zero.

Procedure: Closed Kinetic Chain

Interventions

NMESPROCEDURE

We used a electrical stimulation device with a 2500-Hz carrier frequency. We used four channels in the synchronous mode, with surface electrodes that were simultaneously fixed at the motor points of the quadriceps and hamstrings. Initially, a warm-up protocol that was five minutes long was used at a stimulation frequency of 40 Hz to activate the slow fibers. These fibers activated with a four-second-contraction time (on), a four-second-stimulus rise time, a four-second-stimulation decay time and a 12-second relaxation time (off). We then increased the frequency to 70 Hz to activate the fast fibers for an additional 10 minutes using the parameters described above, and finally, the frequency was increase to 150 Hz for 10 minutes to achieve maximal muscle potentiation.

Also known as: 10-channel NEURODYN electrical stimulation IBRAMED
Closed Kinetic Chain and NMES placebo

During the stimulation period, i.e., the on time, the patient remained in a mini-squat position at thirty degrees and returned to zero degrees during the decay period. During the electrical stimulation off period, the patient spontaneously performed another mini-squat at 30 degrees without electrical stimulation. The patients in the CKC + NMES placebo group simulated the same work applied to the NMES group. Notably, this group was also connected to the electrodes, but the equipment was set at a stimulus intensity of zero.

Also known as: Closed Kinetic Chain exercises
Closed Kinetic Chain Group

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with grade I or grade II knee OA (based on the Kellgren-Lawrence classification;
  • which was diagnosed by a medical traumatologist;
  • radiographic changes that demonstrated a reduced joint space in at least one of the compartments of the knee;
  • subchondral bone sclerosis;
  • consent to participate in the study

You may not qualify if:

  • patients who had grade III and grade IV knee OA (based on the Kellgren-Lawrence classification);
  • who were involved in another rehabilitation program outside the center;
  • who presented with clinical symptoms that would prevent them from participating in the exercises;
  • who had heart disease;
  • cardiac pacemakers;
  • periarticular metal implants;
  • who experienced changes in sensitivity;
  • who had a previous history of knee injury (meniscus, ligaments, sprains);
  • who had uncontrolled diabetes;
  • neurological disorders with cognitive impairments;
  • rheumatic diseases;
  • history of knee trauma in the last six months;
  • prior knee surgery;
  • three consecutive unexcused absences.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis, KneeSelf Stimulation

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBehavior

Study Officials

  • Marcelo Dohnert

    Universidade Luterana do Brasil

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 22, 2011

First Posted

March 23, 2011

Study Start

August 1, 2010

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

March 23, 2011

Record last verified: 2011-03